MedPage Today

FDA Approves Immunotherapy Combo as First Non-Chemotherapy Option for Bladder Cancer

(MedPage Today) -- The FDA approved pembrolizumab (Keytruda) or pembrolizumab and berahyaluronidase alfa (Keytruda Qlex) in combination with enfortumab vedotin (Padcev) as perioperative treatment for adults with muscle-invasive bladder cancer ...